Christine Herman is a Ph.D. chemist turned audio journalist. Her reporting has received awards from the Illinois Associated Press Broadcasters Association and has aired on national programs including All Things Considered and Here & Now. Christine is a mother of three and aspiring aerial artist. She’s a recipient of the 2018-2019 Rosalynn Carter Fellowships for Mental Health Journalism and has been working at Illinois Public Media since 2015.
Christine Herman
Side effects public media
From this contributor
Parents forced to trade custody for children’s mental-health care
Each year, dozens of families in Illinois give up custody of their children to help them get mental-health services.
Parents forced to trade custody for children’s mental-health care
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.